MAIA Biotechnology, Inc.
For the period ended Dec 31, 2024. Filed Mar 21, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 21, 2025
MAIA$1.09+2.8%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Comprehensive Loss
| Years Ended December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Net loss | $(23,254,656) | $(19,772,905) |
| Foreign currency translation adjustment | (14,355) | (287) |
| Comprehensive loss | $(23,269,011) | $(19,773,192) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.